28th Jan 2021 14:26
Genedrive PLC - Manchester-based molecular diagnostics firm - Enters into pact with Beckman Coulter Life Sciences for distribution of Genedrive's 96 SARS-CoV-2 Kit PCR test. Agreement allows Beckman to sell the tests in US and Europe. "We are very pleased to have the partnership of Beckman Coulter in accessing significant Covid testing opportunities throughout the United States and Europe, where the incidence of Covid continues to escalate and the need for high throughout testing solutions remains a priority," Genedrive Chief Executive Officer David Budd says.
Current stock price: 78.50 pence, up 40% on Thursday
Year-to-date change: up 62%
By Eric Cunha; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Genedrive